In summary, we present a machine learning classifier relying on preoperative DTI data to accurately predict IDH mutational status in newly diagnosed WHO grade II and III gliomas, highlighting the potential of non-invasive, MRI-based genotype assessment. This evidence concerns the gene IDH1 and central nervous system cancer.